Federal funding analysis
Reported transaction obligations
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 405 of 405 selected awards have dated, valued transactions.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-39.8M |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $115.1M |
| Change | $-154.9M |
| Growth | -134.5%Why this funding changeNet obligations in equal-length adjacent periods. ($-39,775,111.35 − $115,149,479.34) ÷ $115,149,479.34 × 100 = -134.54%
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Negative obligation adjustments can produce a decline below −100%. |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $74.1M | 3 |
| Department of Defense | $1.2M | 402 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| ASPR/ORM-SNS | $74.1M | 3 |
| DLA TROOP SUPPORT | $912.4K | 2 |
| DLA TROOP SUPPORT | $327.9K | 400 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $74.1M | 3 |
| 325411 — Medicinal and Botanical Manufacturing | $1.2M | 402 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $75.4M | 405 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| 36F79720D0198 | $58.1M | 2 |
| Unclassified | $16.1M | 1 |
| SPE2D020D0005 | $1.2M | 402 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NY | $75.4M | 405 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| SMALL BUSINESS SET ASIDE - TOTAL | $58.1M | 2 |
| NO SET ASIDE USED. | $16.1M | 1 |
| Unclassified | $1.2M | 402 |